enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
1.740
-0.020 (-1.14%)
At close: Nov 20, 2026, 4:00 PM EST
1.700
-0.040 (-2.30%)
After-hours: Nov 20, 2026, 6:52 PM EST
enGene Therapeutics Market Cap
enGene Therapeutics has a market cap or net worth of $116.61 million as of November 20, 2026. It is the 23,522nd most valuable company in the world and the 3,873rd biggest in the United States. Its market cap has decreased by 74.20% in one year.
Market Cap
116.61M
Enterprise Value
-116.44M
1-Year Change
-74.20%
Global Rank
Country Rank
#3,873 United States
Category
ChartMarket Cap Chart
Since February 1, 2022, enGene Therapeutics's market cap has decreased from $155.91M to $116.61M, a decrease of -25.21%. That is a compound annual growth rate of -5.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 116.61M | -80.72% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 125.26M |
| Compass Therapeutics | 123.94M |
| Humacyte | 123.73M |
| Satellos Bioscience | 122.07M |
| Invivyd | 122.01M |
| Adagene | 118.17M |
| Armata Pharmaceuticals | 112.69M |
| Fate Therapeutics | 111.72M |